about
A Study of Nimotuzumab in Combination With External Radiotherapy in Non-Small Cell Lung CancerStudy of Combination of Metronomic Oral Vinorelbine and Sorafenib in Patients With Advanced Non-small Cell Lung CancerSafety and Tolerability Study of RAD001 and LBH589 in All Solid Tumors With Enrichment for EBV Driven Tumors
P6153
Q57623614-99AAF182-3F35-460B-B838-3D51090FD1F6Q59817523-1C63C43F-FE2F-4104-BC1F-2D05A24FD8F8Q61072135-3A228E91-187F-47A3-8FA0-BF6EE4AAE44AQ82265316-99437045-EF83-44D5-AB76-3A0ECE4202EAQ85449357-834F3EFF-DBC2-4C6D-B258-4069BCB7250AQ85653598-AAD232ED-6137-4D43-A234-3BFE315DF334Q88559081-F9AB6041-4DC2-4CC7-B448-3DB76B872748Q89072936-5CA8D14C-B270-4691-84AB-5561D4938A62
P108
description
healthcare organization in Tokyo, Japan
@en
name
National Cancer Centre
@en
type
label
National Cancer Centre
@en
altLabel
NCC
@en
prefLabel
National Cancer Centre
@en
P214
P244
P131
P17
P213
0000 0001 2168 5385
P214
P2427
grid.272242.3
P244
P571
1962-01-01T00:00:00Z
P625
Point (139.940803 35.900035)
P6782
P7859
lccn-n82089931